PepKingContact us
MOTS-C · MITOCHONDRIAL PEPTIDE

Metabolic
Support.

A focused guide to MOTS-c, a mitochondrial-derived peptide discussed for metabolism, insulin sensitivity, endurance, and fat loss. Explore how it is described, the example course, and simple ways to track your response.

Reported benefits are personal experience reports. Effects in healthy people have not been established in controlled trials.

01WHAT MOTS-C IS

A signal from
your mitochondria.

MOTS-c is a short peptide made of 16 amino acids, encoded in mitochondrial DNA. Research describes it acting on AMPK, the cell's energy sensor, and on how muscle takes up and uses glucose. It is sometimes described as exercise-mimetic.

Insulin sensitivity

Community reports describe steadier glucose handling and insulin sensitivity for some people. Track your own response; effects in healthy people have not been established in controlled trials.

Endurance

Community users report more training energy and better workout capacity for some people, which can be tracked alongside the same workouts over time.

Fat loss

Reported as a support to a calorie deficit, not a replacement for it. Keep food, movement, and your weight trend in view. Use the calorie calculator to find a starting point.

What to expect

Community reports describe the effects as subtle and gradual. It is not an appetite suppressant and does not work like a GLP-1. Effects in healthy people have not been established in controlled trials.

02PROPOSED COURSE · FOR CLINICAL REVIEW

Eight weeks on.
Four weeks off.

The example uses two scheduled days each week. Weeks 1–2 list 2.5 mg per scheduled day; weeks 3–8 list 5 mg per scheduled day. A full four-week break follows week 8.

Review the example before use

This is a proposed injectable schedule, not a validated metabolic regimen. A qualified clinician should review the product, dose, and suitability before use; the scheduled break does not establish safety.

PREFERRED TIMING IN THIS EXAMPLE

Morning or early afternoon

The example places scheduled doses in the morning or early afternoon on Monday and Thursday. That window has not been established as more effective than other times; follow the supervising clinician's instructions.

Weeks 1–2

2.5 mg

Per scheduled dayMonday and Thursday in the morning or early afternoon
Weeks 3–8

5 mg

Per scheduled dayMonday and Thursday in the morning or early afternoon
Weeks 9–12

4-week break

No MOTS-cNo MOTS-c during the break
123456789101112

Monday and Thursday on.

All other days are off. The amount shown for each phase applies to its scheduled days. mg = milligrams.

  1. SundayOffNo dose
  2. MondayOnScheduled day
  3. TuesdayOffNo dose
  4. WednesdayOffNo dose
  5. ThursdayOnScheduled day
  6. FridayOffNo dose
  7. SaturdayOffNo dose

After week 8, take the four-week break in the example. Review changes and symptoms before considering another course.

03MAKE PROGRESS EASY TO COMPARE

Same scale.
Same starting point.

Use a consistent record of glucose, training, weight, and waist measurements to compare changes with your starting point.

Track glucose

Compare fasting glucose or continuous glucose monitor (CGM) trends from the same starting point, plus A1c at labs. Review the readings alongside symptoms and other treatments.

Track training

Keep the same workouts where possible. Note energy, endurance, and how much work you can complete comfortably.

Track the body

Compare weekly average weight and waist measurements. Use the same scale, measuring method, and conditions each time.

04INDIVIDUAL CARE

Watch your response.
Adjust with care.

Review the exact product, other treatments, and health conditions with qualified care. Keep symptoms alongside your progress records.

Reported side effects

Personal reports include injection-site pain, redness or itching; fatigue, especially in the first days; a faster heart rate or feeling wired; night sweats, warmth or flushing; and occasional headache or nausea.

Persistent symptoms are a reason to stop and review. Discuss any dose reduction with a clinician before continuing.

Glucose

If you have diabetes or use insulin, monitor blood sugar closely. Changes in insulin sensitivity can change your medication needs. Review the readings with your diabetes clinician before adjusting treatment.

Pregnancy & breastfeeding

Do not use MOTS-c during pregnancy or breastfeeding. Contact the prescriber if planning pregnancy or if pregnancy occurs during use.

Injection-site comfort

How and where to inject: the illustrated subcutaneous guide.

Itching, redness, or mild swelling can occur after injections. A clean, cool compress can help with mild local discomfort. Seek advice if symptoms persist.

Biofreeze Professional spray is for muscle and joint pain. Its label excludes wounded or irritated skin; it is not recommended here for injection-site itching.

Spreading redness, heat, worsening pain, or fever needs prompt assessment. Trouble breathing, facial swelling, or fainting requires emergency care.